Skip to main navigation
Skip to search
Skip to main content
University of Limerick Home
Home
Profiles
Research units
Research output
Prizes
Activities
Press/Media
Student theses
Search by expertise, name or affiliation
Harms of off-label erythropoiesis-stimulating agents for critically ill people
Bita Mesgarpour
, Benedikt H. Heidinger
, Dominik Roth
, Susanne Schmitz
, Cathal D. Walsh
, Harald Herkner
Department of Mathematics and Statistics
National Institute for Medical Research Development (NIMAD)
Medical University of Vienna
Luxembourg Institute of Health
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Harms of off-label erythropoiesis-stimulating agents for critically ill people'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Adverse Event
30%
Anemia
7%
Biosimilar
7%
Blood Product
7%
Clinical Trial
7%
Erythropoietin
7%
Evidence-Based Medicine
7%
Hematinic
100%
Intensive Care
15%
Observational Study
38%
Off-Label Use
23%
Placebo
15%
Random Effects Model
7%
Randomized Controlled Trial
30%
Systemic Administration
7%
Treatment Effect
7%
Venous Thromboembolism
15%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
30%
Anemia
7%
Antianemic Agent
100%
Biosimilar Agent
7%
Clinical Trial
7%
Erythropoietin
7%
Observational Study
38%
Off-Label Use
23%
Placebo
15%
Random Effects Model
7%
Randomized Controlled Trial
30%
Systemic Administration
7%
Venous Thromboembolism
15%